Header Logo

Connection

KEVIN ERICKSON to Kidney Failure, Chronic

Back to Details
This is a "connection" page, showing publications KEVIN ERICKSON has written about Kidney Failure, Chronic.
KEVIN ERICKSON
Connection Strength
11.502
Kidney Failure, Chronic
  1. In-center hemodialysis unit patient experience with telehealth. Hemodial Int. 2023 04; 27(2):193-196.
    View in: PubMed
    Score: 0.494
  2. Fifty Years of a National Program for the Treatment of Kidney Failure. JAMA. 2023 01 17; 329(3):205-206.
    View in: PubMed
    Score: 0.492
  3. A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis. J Am Soc Nephrol. 2022 Nov; 33(11):2059-2070.
    View in: PubMed
    Score: 0.478
  4. Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States. J Am Soc Nephrol. 2022 06; 33(6):1063-1072.
    View in: PubMed
    Score: 0.465
  5. Market Consolidation and Innovation in US Dialysis. Adv Chronic Kidney Dis. 2022 01; 29(1):65-75.
    View in: PubMed
    Score: 0.458
  6. The beneficial effect of providing kidney transplantation information on transplantation status differs between for-profit and nonprofit dialysis centers. Transpl Int. 2021 12; 34(12):2644-2668.
    View in: PubMed
    Score: 0.457
  7. How Did Medicare Payment Reform Affect Highly Concentrated Dialysis Markets? JAMA Health Forum. 2021 11 02; 2(11):e213378.
    View in: PubMed
    Score: 0.453
  8. Patient Health Outcomes following Dialysis Facility Closures in the United States. J Am Soc Nephrol. 2021 10; 32(10):2613-2621.
    View in: PubMed
    Score: 0.450
  9. Payer Mix Among Patients Receiving Dialysis. JAMA. 2020 09 01; 324(9):900-901.
    View in: PubMed
    Score: 0.418
  10. Bundled Payment Reform and Dialysis Facility Closures in ESKD. J Am Soc Nephrol. 2020 03; 31(3):579-590.
    View in: PubMed
    Score: 0.401
  11. Physician reimbursement for outpatient dialysis care: Past, present, and future. Semin Dial. 2020 01; 33(1):68-74.
    View in: PubMed
    Score: 0.400
  12. Consolidation in dialysis Markets-Causes, consequences, and the role of policy. Semin Dial. 2020 01; 33(1):90-99.
    View in: PubMed
    Score: 0.399
  13. The dialysis care-policy issue: Guest Editors' introductory remarks. Semin Dial. 2020 01; 33(1):4.
    View in: PubMed
    Score: 0.399
  14. Bariatric Surgery for ESKD Patients: Why, When, and How? Clin J Am Soc Nephrol. 2019 Aug 07; 14(8):1125-1127.
    View in: PubMed
    Score: 0.387
  15. Integrated Care in ESKD: A Perspective of Nephrologists. Clin J Am Soc Nephrol. 2019 03 07; 14(3):451-453.
    View in: PubMed
    Score: 0.374
  16. Patient-Reported Experiences of Dialysis Care Within a National Pay-for-Performance System. JAMA Intern Med. 2018 10 01; 178(10):1358-1367.
    View in: PubMed
    Score: 0.366
  17. Market Consolidation and Mortality in Patients Initiating Hemodialysis. Value Health. 2019 01; 22(1):69-76.
    View in: PubMed
    Score: 0.361
  18. The Role of Big Data in the Development and Evaluation of US Dialysis Care. Am J Kidney Dis. 2018 10; 72(4):560-568.
    View in: PubMed
    Score: 0.358
  19. Health Insurance and the Use of Peritoneal Dialysis in the United States. Am J Kidney Dis. 2018 04; 71(4):479-487.
    View in: PubMed
    Score: 0.347
  20. Effects of physician payment reform on provision of home dialysis. Am J Manag Care. 2016 06 01; 22(6):e215-23.
    View in: PubMed
    Score: 0.311
  21. Measuring comorbidity in patients receiving dialysis: can we do better? Am J Kidney Dis. 2015 Nov; 66(5):731-4.
    View in: PubMed
    Score: 0.293
  22. Overlooked care transitions: an opportunity to reduce acute care use in ESRD. Clin J Am Soc Nephrol. 2015 Mar 06; 10(3):347-9.
    View in: PubMed
    Score: 0.284
  23. Provider visit frequency and vascular access interventions in hemodialysis. Clin J Am Soc Nephrol. 2015 Feb 06; 10(2):269-77.
    View in: PubMed
    Score: 0.283
  24. Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. J Am Soc Nephrol. 2015 Aug; 26(8):1990-7.
    View in: PubMed
    Score: 0.280
  25. Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. J Am Coll Cardiol. 2013 Mar 26; 61(12):1250-8.
    View in: PubMed
    Score: 0.249
  26. Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations. Clin J Am Soc Nephrol. 2013 Jun; 8(6):987-94.
    View in: PubMed
    Score: 0.248
  27. Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities. Am J Kidney Dis. 2025 Feb; 85(2):226-235.e1.
    View in: PubMed
    Score: 0.139
  28. Geographic Dialysis Facility Density and Early Dialysis Initiation. JAMA Netw Open. 2024 01 02; 7(1):e2350009.
    View in: PubMed
    Score: 0.132
  29. Market Competition and Anemia Management in the United States Following Dialysis Payment Reform. Med Care. 2023 Nov 01; 61(11):787-795.
    View in: PubMed
    Score: 0.129
  30. Barriers to Implementing the Kidney Disease Outcomes Quality Initiative End-Stage Kidney Disease Life Plan Guideline. J Gen Intern Med. 2023 Nov; 38(14):3198-3208.
    View in: PubMed
    Score: 0.127
  31. Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency. Clin J Am Soc Nephrol. 2021 07; 16(7):1052-1060.
    View in: PubMed
    Score: 0.111
  32. Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery. J Am Soc Nephrol. 2020 03; 31(3):602-614.
    View in: PubMed
    Score: 0.100
  33. Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure? JAMA. 2018 12 04; 320(21):2206-2208.
    View in: PubMed
    Score: 0.093
  34. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
    View in: PubMed
    Score: 0.092
  35. Evaluating the Evidence behind Policy Mandates in US Dialysis Care. J Am Soc Nephrol. 2018 12; 29(12):2777-2779.
    View in: PubMed
    Score: 0.092
  36. Health Insurance in the First 3 Months of Hemodialysis and Early Vascular Access. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1866-1875.
    View in: PubMed
    Score: 0.092
  37. Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
    View in: PubMed
    Score: 0.087
  38. A Case for More Frequent, Not Just Earlier, Nephrology Care of Patients Approaching ESRD? Am J Kidney Dis. 2017 08; 70(2):155-157.
    View in: PubMed
    Score: 0.084
  39. Physician visits and 30-day hospital readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2014 Sep; 25(9):2079-87.
    View in: PubMed
    Score: 0.067
  40. Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med. 2013 Sep 17; 159(6):382-9.
    View in: PubMed
    Score: 0.064
  41. Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD. Clin J Am Soc Nephrol. 2013 Jan; 8(1):75-81.
    View in: PubMed
    Score: 0.060
  42. Hemodialysis treatment center early mortality rates for incident hemodialysis patients are associated with the quality of care prior to starting but not following onset of dialysis. Am J Nephrol. 2011; 33(5):390-7.
    View in: PubMed
    Score: 0.054
  43. The challenges of cost-effectiveness analyses for the clinician. Am J Kidney Dis. 2010 Dec; 56(6):1023-5.
    View in: PubMed
    Score: 0.053
  44. Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition. Clin J Am Soc Nephrol. 2017 Mar 07; 12(3):536-545.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.